NATIONAL CANCER INSTITUTE - CANCER.GOV

Home
Scientific Resources
Emerging Technologies
Technology Videos
STARS Funding
Contact Us

Overview of the new Mass Cytometry Core at FNLCR

Spatial Proteomics with Imaging Mass Cytometry
Milind M. Pore, Ph.D., Scientist II, Mass Cytometry Core (MCC), Cancer Research Technology Program, (FNLCR).
Resolving the Osteosarcoma Microenvironment Using Spatial Omics
Troy A. McEachron, Ph.D., Principal Investigator, Pediatric Oncology Branch.
Application of IMC to Inform Lung Immunity in Fatal COVID-19 Cases
Daniel S. Chertow, MD, MPH, Principal Investigator and Head, Emerging Pathogens Section
Stephen M. Hewitt, MD, PhD, Director, Clinical Trials Correlative Core, and Director, CLIA Molecular Diagnostics Laboratory, FNLCR

National Cancer Institute

At the National Institutes of Health

Organization

U.S. Department of Health and Human Services
National Institutes of Health
National Cancer Institute
USA.gov

OSTR

Scientific Resources
STARS Funding
Contact Us

Policies

HHS Vulnerability Disclosure
FOIA
Accessibility
Policies

NIH…Turning Discovery Into Health®